OSHA Workplace Safety - Mpje

1. A pharmacy chain's management team is evaluating whether to implement a closed-system drug transfer device (CSTD) for hazardous drug preparation. Which argument BEST supports adopting CSTDs?
   Answer: CSTDs mechanically prevent escape of drug or vapor during transfer, reducing employee hazardous drug exposure beyond what BSC/CACI containment alone provides Closed-system drug transfer devices (CSTDs) provide an additional layer of protection by mechanically containing hazardous drug aerosols and liquids during preparation and administration. USP 800 recommends CSTDs as a supplemental engineering control during sterile HD compounding, beyond the primary protection of BSCs and CACIs. CSTDs do not eliminate PPE requirements; they supplement, not replace, other controls. CSTDs are not required by the DEA and do not establish ISO air classification.
2. An employer provides free hepatitis B vaccinations to pharmacy employees who administer injections. An employee declines the vaccine. What must the employer do?
   Answer: Obtain a signed declination statement and keep the vaccine available for future acceptance. OSHA's Bloodborne Pathogens Standard allows employees to decline hepatitis B vaccination. If an employee declines, the employer must obtain a signed declination statement, which is retained in the employee's records. The vaccine must remain available to the employee at no cost if they later choose to receive it. Employees cannot be required to accept vaccination or terminated for declination. OSHA does not require notification for individual employee declinations.
3. A pharmacy employee believes the pharmacy is violating OSHA hazardous drug standards and faces retaliation for raising concerns. Under OSHA's whistleblower protection provisions, what protection does the employee have?
   Answer: Employees are protected from retaliation for reporting safety concerns under OSHA whistleblower provisions. OSHA Section 11(c) of the Occupational Safety and Health Act prohibits employers from retaliating against employees who report safety and health concerns, file OSHA complaints, or otherwise exercise their rights under the Act. This protection applies to all employees regardless of licensure status. Employees do not need to report to the DEA first; OSHA complaints are filed directly with OSHA.
4. OSHA requires pharmacies to have a written Exposure Control Plan when employees have occupational exposure to bloodborne pathogens. Which employee group at a retail pharmacy MOST likely requires coverage under this plan?
   Answer: Pharmacists and technicians who administer injections or handle sharps used for patient care OSHA's Bloodborne Pathogens Standard applies to employees who have reasonably anticipated occupational exposure to blood or other potentially infectious materials - including those who administer injections, handle sharps, or may contact blood during immunization services. Not all retail pharmacy employees meet this threshold. The plan is not universally required for all employees regardless of exposure risk, and prior pathogen status is irrelevant to the coverage determination.
5. A pharmacy is disposing of unused hazardous drug waste from compounding activities. Under OSHA and EPA regulations, how must this waste be handled?
   Answer: Hazardous drug waste must be placed in labeled containers and disposed of per EPA and state hazardous waste regulations. Hazardous drug waste is subject to EPA RCRA regulations as hazardous chemical waste. It must be segregated from other waste, collected in clearly labeled hazardous waste containers, and disposed of in compliance with applicable RCRA and state hazardous waste regulations. Depending on the waste classification (P-listed, U-listed, characteristic, or state-regulated) and applicable state implementation, disposal through a licensed hazardous waste contractor is typically required. A correctly identifies this framework while acknowledging state-level variation. B is incorrect because DEA Form 41 applies to the destruction of controlled substances, not hazardous chemical waste disposal. C is incorrect because hazardous drug waste may not be placed in sharps containers and autoclaved; autoclaving addresses biological hazards, not chemical hazards. D is incorrect because drain disposal of hazardous drug waste is prohibited regardless of dilution; dilution does not render hazardous drug waste non-hazardous or eliminate disposal obligations.
6. Under OSHA's Hazard Communication Standard (HazCom), what must pharmacy employers provide to employees who work with hazardous chemicals?
   Answer: Access to Safety Data Sheets (SDS), hazard training, and properly labeled containers OSHA's Hazard Communication Standard (29 CFR 1910.1200) requires employers to provide employees with: (1) Safety Data Sheets for all hazardous chemicals in the workplace; (2) employee training on chemical hazards and protective measures; and (3) properly labeled containers identifying chemical hazards. The DEA, signed waivers, and FDA notifications are not components of HazCom compliance.
7. Which organization publishes the list of hazardous drugs that forms the basis for USP 800 compliance determinations in pharmacy?
   Answer: The National Institute for Occupational Safety and Health (NIOSH) NIOSH publishes the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, which is the authoritative reference used to identify hazardous drugs for purposes of USP 800 and OSHA compliance. USP 800 incorporates the NIOSH list as its basis for defining which drugs require hazardous drug handling precautions. The FDA, DEA, and USP itself do not publish this specific hazardous drug classification list.
8. A pharmacy technician who is pregnant asks to be reassigned away from hazardous drug compounding duties. Under USP 800 and OSHA reproductive hazard guidelines, which response BEST reflects the employer's obligation?
   Answer: The employer must offer an alternative assignment if available and inform the employee of reproductive risks. USP 800 and OSHA guidelines recognize reproductive toxicity as a key hazard of antineoplastic and other hazardous drugs. Employees with reproductive risk -- including pregnant workers, those planning to conceive, and those who are breastfeeding -- must be informed of the risks in writing. The employee then decides whether to continue working with hazardous drugs. USP 800 guidance supports offering alternative assignments to employees who decline HD duties, and applicable federal and state employment and accommodation laws may require this; however, the precise scope of any mandatory reassignment obligation depends on jurisdiction and circumstances. C correctly reflects the core obligations. A is incorrect because denying all accommodation conflicts with both USP 800 guidance and applicable employment laws. B is incorrect because terminating an employee who requests accommodation from reproductive hazards is unlawful discrimination. D is incorrect because a physician's note is not a prerequisite for initiating the accommodation or risk communication process.
9. A hospital pharmacy prepares antineoplastic agents daily. Under USP 800 and OSHA guidelines, what type of ventilated cabinet is required for sterile hazardous drug compounding?
   Answer: A Class II Biological Safety Cabinet (BSC) USP 800 and OSHA guidelines require that sterile hazardous drug compounding (including antineoplastics) be performed in a Class II Biological Safety Cabinet (BSC) or a Compounding Aseptic Containment Isolator (CACI). These devices provide containment to protect workers from drug exposure while maintaining aseptic conditions. Horizontal LAFWs and standard fume hoods do not provide adequate containment. Positive-pressure ISO 5 cleanrooms would expel hazardous particles outward, endangering personnel.
10. A pharmacy employee regularly handles methotrexate tablets for a mail-order operation. The NIOSH list classifies methotrexate as a hazardous drug. What minimum PPE is required under USP 800 for this activity?
    Answer: At minimum, ASTM D6978-compliant chemotherapy gloves; additional PPE based on risk assessment of the specific activity USP 800 requires at minimum one pair of ASTM D6978-tested chemotherapy gloves when handling hazardous drugs in any dosage form, including solid oral dosage forms. Additional PPE (gown, eye/face protection, respiratory protection) is required when handling damaged or broken tablets, performing manipulation, or when splashing/aerosolization risk is present. A PAPR is not universally required for routine tablet handling. Methotrexate's oral form does not exempt it from PPE requirements. DEA Form 222 is for Schedule I/II ordering.
11. A new pharmacy employee is hired to work in the sterile compounding area where hazardous drugs are prepared. Under OSHA and USP 800, when must initial hazardous drug training be completed?
    Answer: Before the employee begins working with hazardous drugs OSHA's Hazard Communication Standard and USP 800 both require that employees receive training on hazardous drug risks before they begin working with or around such drugs. Initial training must occur prior to the first exposure, not after a delay period. Annual retraining is also required. Training cannot be deferred to a CE cycle or contingent on an employee request.
12. A pharmacy employee who regularly handles hazardous drugs requests a copy of her medical surveillance records related to occupational exposure. Under OSHA regulations, what is the employer's obligation?
    Answer: The employer must provide the employee access to her medical surveillance and exposure records upon request, at no cost OSHA's Access to Employee Exposure and Medical Records Standard (29 CFR 1910.1020) grants employees the right to access their occupational exposure records and medical records maintained by the employer, upon request and at no cost. This right is fundamental to worker protection and informed consent regarding occupational health risks. No court order, fee, or formal complaint is required to trigger this right.
13. A pharmacy receives a large spill of a liquid hazardous drug in the compounding area. What is the correct initial response according to OSHA and USP 800 guidelines?
    Answer: Wear PPE, use a spill kit to contain and clean the spill, dispose of materials as hazardous waste. USP 800 and OSHA guidelines require use of a dedicated hazardous drug spill kit and appropriate PPE (chemotherapy-rated gloves, gown, eye protection, and respiratory protection if aerosols may be generated) for hazardous drug spill cleanup. All cleanup materials are hazardous waste and must be disposed of accordingly. Using regular trash is a regulatory violation. The DEA and FDA are not notified of hazardous drug spills; OSHA notification may be required only if an employee is injured.
14. OSHA requires employers to maintain a written program for workplace safety. In a pharmacy context, which document BEST fulfills this requirement for hazardous drug handling?
    Answer: A written Hazardous Drug Safety and Health Plan (HDSHP). USP 800 requires facilities handling hazardous drugs to develop and maintain a written Hazardous Drug Safety and Health Plan (HDSHP) covering hazard assessment, engineering controls, PPE, spill management, training, and medical surveillance. This document addresses the pharmacy's written program obligations for HD handling and substantially aligns with OSHA-required written program elements for hazardous chemical exposure. Note that OSHA's Hazard Communication Standard (29 CFR 1910.1200) separately requires a written HazCom program; the HDSHP and the HazCom program together address the employer's full written program obligations in this context. DEA registration certificates, state board permits, and Medicare provider agreements do not address workplace safety program requirements.
15. A retail pharmacy begins offering immunization services. The pharmacist-in-charge wants to ensure OSHA compliance. Which action is MOST important to address OSHA's Bloodborne Pathogens Standard requirements?
    Answer: Create a written Exposure Control Plan and provide hepatitis B vaccination to eligible employees. When a pharmacy begins administering injections, employees have occupational exposure to bloodborne pathogens (via needlestick risk). OSHA's Bloodborne Pathogens Standard requires: a written Exposure Control Plan identifying at-risk employees; hepatitis B vaccination offered at no cost; employee training on bloodborne hazards and precautions; and sharps disposal containers. State board registration, DEA registration, and FDA notification are not triggered by adding immunization services.
16. A pharmacy director is reviewing the facility's hazardous drug handling program. Which combination of elements BEST demonstrates a comprehensive OSHA- and USP 800-compliant program?
    Answer: Hazardous drug list, SDS, PPE policy, engineering controls, training, spill kits, waste disposal. A comprehensive hazardous drug safety program requires multiple interlocking elements: a facility-specific hazardous drug list (based on NIOSH), accessible SDS, appropriate engineering controls, PPE policies, documented employee training, medical surveillance for regularly exposed workers, available spill kits, and compliant hazardous waste disposal. DEA Form 41 relates to controlled substance destruction. PDMP and DUR are dispensing functions. USP 797 addresses sterile compounding quality - related but distinct from the HD safety program.
17. A pharmacy employee is exposed to a hazardous drug spill and later develops an occupational illness. Under OSHA's recordkeeping requirements, what must the employer do?
    Answer: Record the work-related illness on the OSHA 300 Log and maintain it for 5 years OSHA requires employers to record work-related injuries and illnesses on the OSHA Form 300 (Log of Work-Related Injuries and Illnesses) and retain these records for 5 years. An occupational illness caused by hazardous drug exposure is a recordable event. Reporting to the FDA, DEA, or state board is not required for occupational illness events - those agencies regulate drugs and pharmacy practice, not employee health recordkeeping.
18. USP 800 requires that the negative-pressure buffer room used for sterile hazardous drug compounding undergo environmental wipe sampling. What is the PRIMARY purpose of this requirement?
    Answer: To detect hazardous drug surface contamination and ensure containment controls are effective Wipe sampling under USP 800 is used to detect surface contamination by hazardous drugs in compounding areas and to evaluate the effectiveness of engineering controls, cleaning procedures, and work practices. Positive findings trigger investigation and remediation. ISO air classification is monitored by particle counting, not wipe sampling. Wipe sampling is not a diversion detection tool and is not an OSHA bloodborne pathogen requirement.
19. A retail pharmacy dispenses oral hazardous drugs (e.g., oral antineoplastics). Under USP 800, what minimum personal protective equipment (PPE) must employees wear when handling these medications?
    Answer: Chemotherapy gloves meeting ASTM D6978 standards; additional PPE (gown, eye protection) based on the activity and risk assessment USP 800 requires that employees handling oral hazardous drugs in final dosage form (counting tablets, pouring liquids) wear at minimum one pair of chemotherapy-tested gloves meeting ASTM D6978. Additional PPE such as a gown and eye protection may be required based on the specific activity and institutional risk assessment. Full respiratory protection and Class III BSCs are not universally required for routine oral hazardous drug dispensing. Asserting no PPE is needed conflicts with USP 800 requirements.
20. A pharmacy employee sustains a needlestick injury while handling sharps used in sterile compounding. Under OSHA's Bloodborne Pathogens Standard, what must the employer do immediately?
    Answer: Provide a confidential medical evaluation and document the incident on the OSHA 300 Log. OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) requires employers to provide a confidential post-exposure evaluation and follow-up to employees who sustain needlestick or sharps injuries, including offering hepatitis B vaccination and post-exposure prophylaxis as appropriate. The injury must also be recorded on the OSHA 300 Log. DEA Form 106 is for controlled substance theft/loss; MedWatch is for adverse drug events; state board suspension is not an OSHA-mandated response.

Start this quiz